Remdesivir News and Research

RSS
NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms

NIH funds large Phase 3 clinical trial to test repurposed drugs for treating COVID-19 symptoms

Experimental antiviral drug for COVID-19 shows effectiveness in hamster models

Experimental antiviral drug for COVID-19 shows effectiveness in hamster models

No evidence B.1.1.7. variant worsens symptoms or increases risk of long COVID

No evidence B.1.1.7. variant worsens symptoms or increases risk of long COVID

Alpaca nanobodies effective against South African SARS-CoV-2 variant

Alpaca nanobodies effective against South African SARS-CoV-2 variant

Clinical trial of monoclonal antibody for treating respiratory disease in COVID-19 patients begins

Clinical trial of monoclonal antibody for treating respiratory disease in COVID-19 patients begins

Researchers identify SARS-CoV-2 antiviral compounds using protein assay

Researchers identify SARS-CoV-2 antiviral compounds using protein assay

Inhibition of nsp14 methyltransferase as a potential antiviral target for SARS-CoV-2

Inhibition of nsp14 methyltransferase as a potential antiviral target for SARS-CoV-2

Small molecule inhibitors of SARS-CoV-2 identified by screening

Small molecule inhibitors of SARS-CoV-2 identified by screening

COVID19's cytokine storm ushers in a local complement storm in the lungs

COVID19's cytokine storm ushers in a local complement storm in the lungs

Screening for SARS-CoV-2 non-structural protein 14 inhibitors

Screening for SARS-CoV-2 non-structural protein 14 inhibitors

Researchers unveil new SARS-CoV-2 inhibitor that targets viral immune evasion

Researchers unveil new SARS-CoV-2 inhibitor that targets viral immune evasion

Researchers identify several novel SARS-CoV-2 inhibitors

Researchers identify several novel SARS-CoV-2 inhibitors

UNION therapeutics’ COVID-19 candidates show promising results in phase 1 study

UNION therapeutics’ COVID-19 candidates show promising results in phase 1 study

CoVIg-19 Plasma Alliance announces outcomes of NIH-funded Phase 3 ITAC clinical trial

CoVIg-19 Plasma Alliance announces outcomes of NIH-funded Phase 3 ITAC clinical trial

Researchers Identify potent small molecule inhibitors against SARS-CoV-2

Researchers Identify potent small molecule inhibitors against SARS-CoV-2

Chemical inhibitor can reduce SARS-CoV-2's ability to infect host cell lines

Chemical inhibitor can reduce SARS-CoV-2's ability to infect host cell lines

Scientists identify nine potential new COVID-19 treatments

Scientists identify nine potential new COVID-19 treatments

Researchers offer large-scale screening of potential broad-spectrum SARS-CoV-2 antivirals

Researchers offer large-scale screening of potential broad-spectrum SARS-CoV-2 antivirals

FDA-approved cancer drug blunts SARS-CoV-2 protein's detrimental effects

FDA-approved cancer drug blunts SARS-CoV-2 protein's detrimental effects

Selecting SARS-CoV-2 inhibitors in human airway epithelial cells

Selecting SARS-CoV-2 inhibitors in human airway epithelial cells